NYSE:MCS

The Marcus Stock Forecast, Price & News

$21.66
+0.28 (+1.31 %)
(As of 06/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$21.23
$21.79
50-Day Range
$18.30
$22.62
52-Week Range
$6.84
$24.71
Volume129,567 shs
Average Volume504,790 shs
Market Capitalization$679.93 million
P/E RatioN/A
Dividend YieldN/A
Beta1.93
30 days | 90 days | 365 days | Advanced Chart
Receive MCS News and Ratings via Email

Sign-up to receive the latest news and ratings for The Marcus and its competitors with MarketBeat's FREE daily newsletter.


The Marcus logo

About The Marcus

The Marcus Corporation, together with its subsidiaries, owns and operates movie theatres, and hotels and resorts in the United States. As of March 4, 2021, it owned or operated 1,097 screens at 89 movie theatre locations in 17 states under the Marcus Theatres, Movie Tavern by Marcus, and BistroPlex brands; and owned and managed 18 hotels, resorts, and other properties in 8 states. The company also operates a family entertainment center under the Funset Boulevard name in Appleton, Wisconsin, as well as owns and operates a retail outlet under the name of Ronnie's Plaza in St. Louis, Missouri. In addition, it provides hospitality management services, including check-in, housekeeping, and maintenance for a vacation ownership development. The company was founded in 1935 and is headquartered in Milwaukee, Wisconsin.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.54 out of 5 stars

Consumer Discretionary Sector

161st out of 598 stocks

Motion Picture Theaters Industry

1st out of 5 stocks

Analyst Opinion: 2.5Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











The Marcus (NYSE:MCS) Frequently Asked Questions

Is The Marcus a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for The Marcus in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" The Marcus stock.
View analyst ratings for The Marcus
or view top-rated stocks.

What stocks does MarketBeat like better than The Marcus?

Wall Street analysts have given The Marcus a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but The Marcus wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting The Marcus?

The Marcus saw a decline in short interest during the month of May. As of May 28th, there was short interest totaling 4,250,000 shares, a decline of 17.2% from the May 13th total of 5,130,000 shares. Based on an average trading volume of 349,100 shares, the short-interest ratio is currently 12.2 days. Currently, 19.7% of the shares of the company are short sold.
View The Marcus' Short Interest
.

When is The Marcus' next earnings date?

The Marcus is scheduled to release its next quarterly earnings announcement on Tuesday, August 3rd 2021.
View our earnings forecast for The Marcus
.

How were The Marcus' earnings last quarter?

The Marcus Co. (NYSE:MCS) released its earnings results on Wednesday, May, 5th. The company reported ($0.96) EPS for the quarter, beating the Zacks' consensus estimate of ($1.21) by $0.25. The business earned $50.79 million during the quarter, compared to analyst estimates of $45.62 million. The Marcus had a negative trailing twelve-month return on equity of 28.14% and a negative net margin of 103.57%.
View The Marcus' earnings history
.

How has The Marcus' stock price been impacted by COVID-19 (Coronavirus)?

The Marcus' stock was trading at $18.70 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MCS shares have increased by 15.8% and is now trading at $21.66.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for MCS?

2 analysts have issued 1 year target prices for The Marcus' shares. Their forecasts range from $25.00 to $25.00. On average, they anticipate The Marcus' stock price to reach $25.00 in the next year. This suggests a possible upside of 15.4% from the stock's current price.
View analysts' price targets for The Marcus
or view top-rated stocks among Wall Street analysts.

Who are The Marcus' key executives?

The Marcus' management team includes the following people:
  • Mr. Gregory S. Marcus, Pres, CEO & Director (Age 56, Pay $955.09k)
  • Mr. Douglas A. Neis, Exec. VP, CFO & Treasurer (Age 62, Pay $656.09k)
  • Mr. Thomas F. Kissinger, Sr. EVP, Gen. Counsel & Sec. (Age 61, Pay $688.83k)
  • Mr. Rolando B. Rodriguez, Exec. VP (Age 61, Pay $824.18k)
  • Mrs. Kim M. Lueck, Chief Information Officer
  • Mr. John E. Murray, VP of HR
  • Mr. Jim Waldvogel, MD for The Hilton Minneapolis/Bloomington Hotel & Crowne Plaza Minneapolis Northstar Downtown
  • Mr. Michael R. Evans, Pres of Marcus Hotels & Resorts division
  • Mr. Steven S. Bartelt, Director of Legal Affairs & Assistant Sec.

What is Gregory S. Marcus' approval rating as The Marcus' CEO?

32 employees have rated The Marcus CEO Gregory S. Marcus on Glassdoor.com. Gregory S. Marcus has an approval rating of 56% among The Marcus' employees. This puts Gregory S. Marcus in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of The Marcus' key competitors?

What other stocks do shareholders of The Marcus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other The Marcus investors own include AT&T (T), AbbVie (ABBV), Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Laboratories (ABT), Verizon Communications (VZ), The Procter & Gamble (PG), Canadian Natural Resources (CNQ), Cisco Systems (CSCO) and Delta Air Lines (DAL).

What is The Marcus' stock symbol?

The Marcus trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCS."

Who are The Marcus' major shareholders?

The Marcus' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (11.71%), Dimensional Fund Advisors LP (4.15%), Victory Capital Management Inc. (2.66%), Gamco Investors INC. ET AL (2.29%), Corre Partners Management LLC (1.68%) and Royce & Associates LP (1.68%). Company insiders that own The Marcus stock include David M Baum, Diane M Gershowitz, Douglas A Neis, Gregory S Marcus, Rolando B Rodriguez and Thomas F Kissinger.
View institutional ownership trends for The Marcus
.

Which major investors are selling The Marcus stock?

MCS stock was sold by a variety of institutional investors in the last quarter, including Cooper Creek Partners Management LLC, Morgan Stanley, Millennium Management LLC, Barclays PLC, Credit Suisse AG, Voloridge Investment Management LLC, Dimensional Fund Advisors LP, and Western Standard LLC. Company insiders that have sold The Marcus company stock in the last year include David M Baum, Diane M Gershowitz, Douglas A Neis, Gregory S Marcus, and Rolando B Rodriguez.
View insider buying and selling activity for The Marcus
or view top insider-selling stocks.

Which major investors are buying The Marcus stock?

MCS stock was acquired by a variety of institutional investors in the last quarter, including Royce & Associates LP, Putnam Investments LLC, Lord Abbett & CO. LLC, Victory Capital Management Inc., BlackRock Inc., Walthausen & Co. LLC, Rutabaga Capital Management LLC MA, and Gabelli Funds LLC.
View insider buying and selling activity for The Marcus
or or view top insider-buying stocks.

How do I buy shares of The Marcus?

Shares of MCS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is The Marcus' stock price today?

One share of MCS stock can currently be purchased for approximately $21.66.

How much money does The Marcus make?

The Marcus has a market capitalization of $679.93 million and generates $237.69 million in revenue each year. The company earns $-124,840,000.00 in net income (profit) each year or ($4.13) on an earnings per share basis.

How many employees does The Marcus have?

The Marcus employs 4,200 workers across the globe.

When was The Marcus founded?

The Marcus was founded in 1935.

What is The Marcus' official website?

The official website for The Marcus is www.marcuscorp.com.

Where are The Marcus' headquarters?

The Marcus is headquartered at 100 EAST WISCONSIN AVENUE SUITE 1900, MILWAUKEE WI, 53202.

How can I contact The Marcus?

The Marcus' mailing address is 100 EAST WISCONSIN AVENUE SUITE 1900, MILWAUKEE WI, 53202. The company can be reached via phone at 414-905-1000 or via email at [email protected]


This page was last updated on 6/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.